Umeå based Inficure Bio and InnoSer have teamed up to offer Inficure Bio’s spontaneous liver inflammation & fibrosis mouse model (NIF mouse) as part of InnoSer’s expanding cardio-metabolic services portfolio. This is the third signed international agreement in a month for InfiCure Bio.
"This expansion will enable us to increase productivity and deliver more products to the market”, says Niklas Norgren, VP and Managing Director.
The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies. "This is yet more proof of the need for and the potential of our model" says Sofia Mayans, CEO of InciCure Bio.
The former CEO of chemical industry giant Perstorp Martin Lundin has been appointed Chairman of the Board for Umeå-based Spinchem AB. “Spinchem combines fascinating cutting-edge technology with talented employees while operating in an exciting market”, says Martin Lundin.
Umeå Biotech Incubator (UBI) is ranked as one of the best Life science incubators in Europa. Now UBI launches an international incubator program. “If you strive to be one of the world's best incubators you must have the whole world as your marketplace”, says Jennie Ekbeck, CEO of UBI.
The Umeå company Xerum has received a new national assignment to measure the presence of antibodies against SARS-CoV-2, the virus that causes covid-19 in Sweden. Xerum has performed and analyzed around 10 000 tests during the pandemic.
Mucocort AB is a Swedish company that has developed a unique self-absorbing pain relief patch for people suffering from recurrent mouth ulcers - aphthous stomatitis. The company has now signed a production agreement with medical technology company Aurena Laboratories AB, which also becomes a stakeholder in Mucocort.
The Umeå-based biopharmaceutical company Omnio AB, focusing on wound healing, has received a capital injection of 1.5 million euros from its shareholders, which will be used for ongoing development work and to begin creating a blueprint for manufacturing.
Tomas Ruuth is the new Head of PR and Communications at Umeå Biotech Incubator.
The Umeå based company Nordic Biomarker has won the award The Export Success of the Year in Sweden.
Umeå-based Lipum will reach an important milestone in its history this year as clinical trials begin on its antibody to treat inflammatory diseases. No less than 17 consultants are now involved in the drug’s development.
Swedish biotech company Agrisera has nearly doubled its workforce in the past two years, having recently moved to new and larger premises. “Demand for our products and services is increasing rapidly. We are in a growth phase and will seek additional talent in the future”, says Erika Gelfgren, CEO of Agrisera.